Journal of NeuroVirology

, Volume 16, Issue 1, pp 93–100

Delayed-onset and recurrent limb weakness associated with West Nile virus infection

  • James J. Sejvar
  • Larry E. Davis
  • Erica Szabados
  • Alan C. Jackson
Case Report

Abstract

Human neurologic illness following infection with West Nile virus (WNV) may include meningitis, encephalitis, and acute flaccid paralysis (AFP). Most WNV-associated AFP is due to involvement of the spinal motor neurons producing an anterior (polio)myelitis. WNV poliomyelitis is typically characterized by acute and rapidly progressing limb weakness occurring early in the course of illness, which is followed by death or clinical plateauing with subsequent improvement to varying degrees. We describe four cases of WNV poliomyelitis in which the limb weakness was characterized by an atypical temporal pattern, including one case with onset several weeks after illness onset, and three cases developing relapsing or recurrent limb weakness following a period of clinical plateauing or improvement. Delayed onset or recurrent features may be due to persistence of viral infection or delayed neuroinvasion with delayed injury by excitotoxic or other mechanisms, by immune-mediated mechanisms, or a combination thereof. Further clinical and pathogenesis studies are needed to better understand the mechanisms for these phenomena. Clinicians should be aware of these clinical patterns in patients with WNV poliomyelitis.

Keywords

myelitis neuroinvasive disease poliomyelitis West Nile virus 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ahmed S, Libman R, Wesson K, Ahmed F, Einberg K (2000). Guillain-Barré syndrome: an unusual presentation of West Nile virus infection. Neurology 55: 144–146.PubMedGoogle Scholar
  2. Al-Shekhlee A, Katirji B (2004). Electrodiagnostic features of acute paralytic poliomyelitis associated with West Nile virus infection. Muscle Nerve 29: 376–380.PubMedCrossRefGoogle Scholar
  3. Asbury AK, Cornblath DR (1990). Assessment of current diagnostic criteria for Guillain-éBarré syndrome. Ann Neurol 27(Suppl): S21-S24.PubMedCrossRefGoogle Scholar
  4. Bendz P (1954). Pain associated with acute poliomyelitis; neurologic and therapeutic considerations. AMA Am J Dis Child 88: 141–147.PubMedGoogle Scholar
  5. Brighton SW, Simson IW (1984). A destructive arthropathy following Chikungunya virus arthritis—a possible association. Clin Rheumatol 3: 253–258.PubMedCrossRefGoogle Scholar
  6. Carmona RJ, Shaikh S, Khalidi NA (2008). Chikungunya viral polyarthritis. J Rheumatol 35: 935–936.PubMedGoogle Scholar
  7. Darman J, Backovic S, Dike S, Maragakis NJ, Krishnan C, Rothstein JD, Irani DN, Kerr DA (2004). Viral-induced spinal motor neuron death is non-cell-autonomous and involves glutamate excitotoxicity. J Neurosci 24: 7566–7575.PubMedCrossRefGoogle Scholar
  8. Feasby TE, Gilbert JJ, Brown WF, Bolton CF, Hahn AF, Koopman WF, Zochodne DW (1986). An acute axonal form of Guillain-Barré polyneuropathy. Brain 109(Pt 6): 1115–1126.PubMedCrossRefGoogle Scholar
  9. Flaherty ML, Wijdicks EF, Stevens JC, Daube JR, Chenworth EC, Helou EF, Sohail MR (2003). Clinical and electrophysiologic patterns of flaccid paralysis due to West Nile virus. Mayo Clin Proc 78: 1245–1248.PubMedCrossRefGoogle Scholar
  10. Glass JD, Samuels O, Rich MM (2002). Poliomyelitis due to West Nile virus. N Engl J Med 347: 1280–1281.PubMedCrossRefGoogle Scholar
  11. Hayes EB (2005). Virology, pathology, and clinical manifestations of West Nile virus disease. Emerg Infect Dis 11: 1174–1179.PubMedGoogle Scholar
  12. Heckmann JG, Sommer JB, Druschky A, Erbguth FJ, Steck AJ, Neundorfer B (1999). Acute motor axonal neuropathy associated with IgM anti-GM1 following Mycoplasma pneumoniae infection. Eur Neurol 41: 175–176.PubMedCrossRefGoogle Scholar
  13. Hughes RA, Cornblath DR (2005). Guillain-Barré syndrome. Lancet 366: 1653–1666.PubMedCrossRefGoogle Scholar
  14. Johnson R (ed) (1998). Postinfectious demyelinating disease. Philadelphia, New York: Lippincott-Raven.Google Scholar
  15. Kraushaar G, Patel R, Stoneham GW (2005). West Nile virus: a case report with flaccid paralysis and cervical spinal cord: MR imaging findings. AJNR Am J Neuroradiol 26: 26–29.PubMedGoogle Scholar
  16. Kuno G (2001). Persistence of arboviruses and antiviral antibodies in vertebrate hosts: its occurrence and impacts. Rev Med Virol 11: 165–190.PubMedCrossRefGoogle Scholar
  17. Leis AA, Stokic DS (2005). Neuromuscular manifestations of human West Nile virus infection. Curr Treat Options Neurol 7: 15–22.PubMedCrossRefGoogle Scholar
  18. Leis AA, Stokic DS, Polk JL, Dostrow V, Winkelmann M (2002). A poliomyelitis-like syndrome from West Nile virus infection. N Engl J Med 347: 1279–1280.PubMedCrossRefGoogle Scholar
  19. Leis AA, Stokic DS, Webb RM, Slavinski SA, Fratkin J (2003). Clinical spectrum of muscle weakness in human West Nile virus infection. Muscle Nerve 28: 302–308.PubMedCrossRefGoogle Scholar
  20. Li J, Loeb JA, Shy ME, Shah AK, Tselis AC, Kupski WJ, Lewis RA (2003). Asymmetric flaccid paralysis: a neuromuscular presentation of West Nile virus infection. Ann Neurol 53: 703–710.PubMedCrossRefGoogle Scholar
  21. Malzberg MS, Rogg JM, Tate CA, Zayas V, Easton JD (1993). Poliomyelitis: hyperintensity of the anterior horn cells on MR images of the spinal cord. AJR Am J Roentgenol 161: 863–865.PubMedGoogle Scholar
  22. Morrey JD, Siddharthan V, Wang H, Hall JO, Skirpstunas RT, Olsen AL, Nordstrom JL, Koenig S, Johnson S, Diamond MS (2008). West Nile virus-induced acute flaccid paralysis is prevented by monoclonal antibody treatment when administered after infection of spinal cord neurons. J NeuroVirol 14: 152–163.PubMedCrossRefGoogle Scholar
  23. Nargi-Aizenman JL, Griffin DE (2001). Sindbis virus-induced neuronal death is both necrotic and apoptotic and is ameliorated by N-methyl-D-aspartate receptor antagonists. J Virol 75: 7114–7121.PubMedCrossRefGoogle Scholar
  24. Oh SJ, Kurokawa K, de Almeida DF, Ryan HF Jr, Claussen GC (2003). Subacute inflammatory demyelinating polyneuropathy. Neurology 61: 1507–1512.PubMedGoogle Scholar
  25. Park E, Velumian AA, Fehlings MG (2004). The role of excitotoxicity in secondary mechanisms of spinal cord injury: a review with an emphasis on the implications for white matter degeneration. J Neurotrauma 21: 754–754.PubMedCrossRefGoogle Scholar
  26. Park M, Hui JS, Bartt RE (2003). Acute anterior radiculitis associated with West Nile virus infection. J Neurol Neurosurg Psychiatry 74: 823–825.PubMedCrossRefGoogle Scholar
  27. Penn RG, Guarner J, Sejvar JJ, Hartman H, McComb RD, Nevins DL, Bhatnagar J, Zaki SR (2006). Persistent neuroinvasive West Nile virus infection in an immunocompromised patient. Clin Infect Dis 42: 680–683.PubMedCrossRefGoogle Scholar
  28. Saad M, Youssef S, Kirschke D, Shubair M, Haddadin D, Myers J, Moorman J (2005). Acute flaccid paralysis: the spectrum of a newly recognized complication of West Nile virus infection. J Infect 51: 120–127.PubMedCrossRefGoogle Scholar
  29. Samuel MA, Wang H, Siddharthan V, Morrey JD, Diamond MS (2007). Axonal transport mediates West Nile virus entry into the central nervous system and induces acute flaccid paralysis. Proc Natl Acad Sci U S A 104: 17140–17145.PubMedCrossRefGoogle Scholar
  30. Sejvar JJ, Bode AV, Marfin AA, Campbell GL, Ewing D, Mazowiecki M, Pavot PV, Schmitt J, Pape J, Biggerstaff BJ, Petersen LR (2005). West Nile virus-associated flaccid paralysis. Emerg Infect Dis 11: 1021–1027.PubMedGoogle Scholar
  31. Sejvar JJ, Bode AV, Marfin AA, Campbell GL, Pape J, Biggerstaff BJ, Petersen LR (2006). West Nile Virus-associated flaccid paralysis outcome. Emerg Infect Dis 12: 514–516.PubMedCrossRefGoogle Scholar
  32. Sejvar JJ, Leis AA, Stokic DS, Van Gerpen JA, Marfin AA, Webb R, Haddad MB, Tierney BC, Slavinski SA, Polk JL, Dostrow V, Winkelmann M, Petersen LR (2003). Acute flaccid paralysis and West Nile virus infection. Emerg Infect Dis 9: 788–793.PubMedGoogle Scholar
  33. Sumner N, Jones L (2008). Multifocal neuropathy associated with West Nile virus infection. Neurology 71: 1123.PubMedCrossRefGoogle Scholar
  34. Sun H, Kawahara Y, Ito K, Kanazawa I, Kwak S (2006). Slow and selective death of spinal motor neurons in vivo by intrathecal infusion of kainic acid: implications for AMPA receptor-mediated excitotoxicity in ALS. J Neurochem 98: 782–791.PubMedCrossRefGoogle Scholar
  35. Tenembaum S, Chitnis T, Ness J, Hahn JS (2007). Acute disseminated encephalomyelitis. Neurology 68: S23-S36.PubMedCrossRefGoogle Scholar
  36. Tyler KL, Pape J, Goody RJ, Corkill M, Kleinschmidt-DeMasters BK (2006). CSF findings in 250 patients with serologically confirmed West Nile virus meningitis and encephalitis. Neurology 66: 361–365.PubMedCrossRefGoogle Scholar
  37. Van der Meche FG, Van Doorn PA, Meulstee J, Jennekens FG (2001). Diagnostic and classification criteria for the Guillain-Barré syndrome. Eur Neurol 45: 133–139.PubMedCrossRefGoogle Scholar

Copyright information

© Journal of NeuroVirology, Inc. 2010

Authors and Affiliations

  • James J. Sejvar
    • 1
  • Larry E. Davis
    • 2
    • 3
  • Erica Szabados
    • 4
  • Alan C. Jackson
    • 5
  1. 1.Division of Viral and Rickettsial Diseases, Division of Vector-Borne Infectious Diseases, National Center for Zoonotic, Vectorborne, and Enteric DiseasesCenters for Disease Control and PreventionAtlantaUSA
  2. 2.Neurology ServiceNew Mexico VA Health Care SystemAlbuquerqueUSA
  3. 3.Department of NeurologyUniversity of New Mexico School of MedicineAlbuquerqueUSA
  4. 4.Department of Clinical Neurosciences (Neurology) (Clinical)Warren Alpert Medical School of Brown UniversityProvidenceUSA
  5. 5.Departments of Internal Medicine (Neurology) and of Medical MicrobiologyUniversity of ManitobaWinnipegCanada

Personalised recommendations